NDA 18543, held by Intl Medication. Lidocaine Hydrochloride.
As of Nov 13, 2026, NDA 18543 (Lidocaine Hydrochloride), held by Intl Medication, was not approved, with 0 approved supplements and 0 published complete response letters.
| Lidocaine Hydrochloride1GM/VIAL · injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Lidocaine Hydrochloride2GM/VIAL · injectable;injection | Lidocaine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
